AC Immune (ACIU) Retained Earnings (2014 - 2026)

AC Immune (ACIU) has reported Retained Earnings for 12 consecutive years, with -$578.3 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings fell 134524.84% year-over-year to -$578.3 billion; the TTM figure through Mar 2026 stood at -$578.3 billion (down 134524.84% YoY), while the FY2025 annual figure was -$529.5 billion, down 125869.34% from the prior year.
• Retained Earnings slipped to -$578.3 billion in Q1 2026 per ACIU's latest filing, from -$549.3 billion in the prior quarter.
• Across five years, Retained Earnings topped out at -$251.6 million in Q3 2022 and bottomed at -$578.3 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$115.6 billion across 5 years, with a median of -$420.4 million in 2024.
• Annual changes were most pronounced in 2024 — Retained Earnings soared 99.88% — and 2026, when it plunged 134524.84%.
• AC Immune's Retained Earnings stood at -$274.1 million in 2022, then sank by 129971.79% to -$356.5 billion in 2023, then jumped by 99.88% to -$420.4 million in 2024, then tumbled by 130573.5% to -$549.3 billion in 2025, then decreased by 5.28% to -$578.3 billion in 2026.
• Business Quant data shows ACIU's Retained Earnings at -$578.3 billion in Q1 2026, -$549.3 billion in Q4 2025, and -$524.7 million in Q3 2025.